XtalPi (HKG:2228) reported a loss attributable to equity holders of the company of 251.9 million yuan for the first half compared with a profit of 82.8 million yuan a year earlier.
The biotech company's loss per share stood at 0.06 yuan, compared with earnings per share of 0.02 yuan in the year-ago period, according to a Wednesday filing with the Hong Kong Exchange.
Revenue decreased to 393.6 million yuan for the six months ended June 30 from 517.1 million yuan.